Navigation Links
ChromaDex Launches pTeroPure Pterostilbene
Date:4/26/2010

IRVINE, Calif., April 26 /PRNewswire-FirstCall/ -- ChromaDex Corporation (OTC Bulletin Board: CDXC), a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today the launch of pTeroPure™ pterostilbene(tero-STILL-bean). This exciting new product introduction is based on the grant of an exclusive worldwide license to all patent rights of pterostilbene from the University of Mississippi and the Agricultural Research Service, which is the principle intramural scientific agency of the U.S. Department of Agriculture. The term of the license is up to and including the expiration of various pterostilbene patents held by the licensors.

As a result of the licensing agreement, ChromaDex plans to immediately pursue clinical studies and commercialization of its new product, pTeroPure™ pterostilbene (http://www.pteropure.com/).

Commenting on the announcement, ChromaDex CEO, Frank Jaksch, stated, "pTeroPure Pterostilbene has the potential to be one of the most significant, new ingredients the dietary supplement industry has seen in a long time.  Most people may not yet know of pterostilbene, but we, and others, believe this naturally occurring compound's improved activity and potency may soon make it as well known as its highly-successful, well known relative, resveratrol."

Pterostilbene is chemically related to resveratrol, a compound that can be found in grapes, blueberries, and other small fruits, as
'/>"/>

SOURCE ChromaDex Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc.
2. ChromaDex Announces Second Quarter 2008 Financial Results
3. ChromaDex Announces 2008 Year End Financial Results
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22. 2015  Varian Medical Systems (NYSE: VAR ... honored for its commitment to sustainability with inclusion on a ... the highest ranked healthcare equipment company among the Corporate Knights ... World Economic Forum at Davos, Switzerland . ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ) ... ) has submitted a pre-market approval application to the ... of Medtronic,s SynchroMed ® II implantable drug infusion ... United Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   ... disease, announced today that the Company closed its ... Investment Management, Jack W. Schuler , Birchview ... were $10.5 million, before offering expenses.  The proceeds ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... NEWTON, Mass., Aug. 11 Microfluidics International Corporation (OTC Bulletin ... June 30, 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NE59652LOGO ... , , Achieved positive earnings before ... Delivered strong bookings of $6.6 million with a backlog ...
... , BEIJING, Aug. 11 /PRNewswire-Asia/ -- ... provider of vaccines in China, today announced,that it will host ... a.m.,ET to review the Company,s second quarter financial results for ... recent corporate developments. , To access ...
... , , WALTHAM, Mass., Aug. ... advisory firms for pharmaceutical and healthcare issues, finds that the entry ... drug market to more than quadruple from approximately $420 million in ... The new Pharmacor report entitled Systemic Lupus Erythematosus ...
Cached Biology Technology:Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 2Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 3Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 4Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 5Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 6Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 7Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 8Microfluidics International Corporation Announces Second Quarter 2009 Financial Results 9Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results 2Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018 2
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2
... work toward making genetically altered bacteria create living "circuits" ... they have logically assumed that the single-celled organisms would ... way. Alas, some bacteria apparently have an individualistic ... A new set of experiments by Duke University ...
... / b3c newswire / - KINAXO Biotechnologies GmbH ... service portfolio. KinAffinity provides invaluable information about a ... of interest. It simultaneously determines affinities for native ... overcomes the limitations of traditional biochemical assays that ...
... 2, 2009 Case Western Reserve University School of Medicine ... Maricich, M.D., Ph.D., and his team found that Merkel ... lineage, as previously speculated. The study, "Mammalian ... recently published in the online version of Developmental ...
Cached Biology News:Understanding a cell's split personality aids synthetic circuits 2Understanding a cell's split personality aids synthetic circuits 3KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue 2Case Western Reserve University discovers Merkel cell originates from skin, not the neural crest 2